You are here

GDC-0973

Genentech takes Exelixis drug into Phase III melanoma trial

Bizjournals.com

Thu, 01/17/13 - 10:19 am

Exelixis: First Partnered Program Enters Phase III

Seeking Alpha

Wed, 10/3/12 - 11:20 am

Exelixis Announces Data Presentation for GDC-0973 (XL518)

Yahoo/BusinessWire

Sat, 09/29/12 - 11:59 am